Drug profile · INN
gadoterate meglumine
GADOTERATE MEGLUMINE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
gadoterate meglumine (GADOTERATE MEGLUMINE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN gadoterate meglumine
Brand GADOTERATE MEGLUMINE
Route INTRAVENOUS
Formulation SOLUTION
Frequently asked questions
What is gadoterate meglumine?
gadoterate meglumine (GADOTERATE MEGLUMINE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for gadoterate meglumine?
GADOTERATE MEGLUMINE is a marketed brand name for gadoterate meglumine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gadoterate meglumine?
gadoterate meglumine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.